Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2018 - 2025)
Chemomab Therapeutics (CMMB) posted Interest Coverage Ratio of 12550.0 for Q4 2025, up 47.13% on a QoQ basis from 8529.74 in Q4 2024, and up 47.13% year-over-year from 8529.74 in Q4 2024.
Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
Chemomab Therapeutics' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 12550.0 for Q4 2025.
- Quarterly Interest Coverage Ratio rose 47.13% year-over-year to 12550.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 20114.97 (up 135.81% YoY) and the FY2025 annual result came in at 0.82, up 19.71% from the prior year.
- Interest Coverage Ratio was 12550.0 for Q4 2025 at Chemomab Therapeutics, up from 8529.74 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 12550.0 in Q4 2025 and bottomed at 0.86 in Q4 2021.
- A 5-year average of 4216.58 and a median of 1.2 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio dropped 10.16% — and 2024, when it soared 790712.57%.
- Chemomab Therapeutics' Interest Coverage Ratio stood at 0.86 in 2021, then jumped by 39.56% to 1.2 in 2022, then dropped by 10.16% to 1.08 in 2023, then surged by 790712.57% to 8529.74 in 2024, then surged by 47.13% to 12550.0 in 2025.
- Business Quant data shows CMMB's Interest Coverage Ratio at 12550.0 in Q4 2025, 8529.74 in Q4 2024, and 1.08 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - | 12,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,550.00 |
| Dec 31, 2024 | 8,529.74 |
| Dec 31, 2023 | 1.08 |
| Dec 31, 2022 | 1.20 |
| Dec 31, 2021 | 0.86 |
| Dec 31, 2020 | -24.85 |
| Dec 31, 2019 | -12,689.60 |
| Sep 30, 2019 | 0.31 |
| Jun 30, 2019 | 246.83 |
| Mar 31, 2019 | 247.00 |
| Dec 31, 2018 | 62.00 |
| Sep 30, 2018 | 34.79 |
| Jun 30, 2018 | 5.16 |